In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example-Reference-Cited by-同舟云学术

In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example

Published:2015-01 Issue: Volume:66 Page:163-172
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Xie Feifan,Ji Shan,Cheng Zeneng

Funder

National Science and Technology

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a Class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets;Basalious;AAPS PharmSciTech,2011

2. Design and Analysis of Bioavailability and Bioequivalence Studies;Chow,2000

3. The development of USP dissolution and drug release standards;Cohen;Pharm. Res.,1990

4. An alternative method to the evaluation of similarity factor in dissolution testing;Costa;Int. J. Pharm.,2001

5. Modeling and comparison of dissolution profiles;Costa;Eur. J. Pharm. Sci.,2001

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed combination of rivaroxaban and Aspirin: Tablet formulation and analytical method validation;Talanta Open;2024-08

2. Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling;The AAPS Journal;2024-07-12

3. Exploration of Abiraterone acetate loaded Nanostructured lipid carriers for bioavailability improvement and circumvention of fast-fed variability;Drug Delivery and Translational Research;2024-07-12

4. A Quality by Design Approach for Optimizing Solid Lipid Nanoparticles of Bedaquiline for Improved Product Performance;AAPS PharmSciTech;2024-07-01

5. Selection of different factors for the Calculation of Similarity factor (f2) and Dissimilarity factor (f1) as per different countries' regulatory recommendations for the biowaiver Study: A Systematic Review;Research Journal of Pharmacy and Technology;2024-03-31